Pharmacology

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Dr. Omar Tupayachi - 5 June, 2026 0

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Dr. Juan Manuel Pérez - 4 June, 2026 0

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...

Left Atrial Appendage Closure in Spain: Sustained Growth and Favorable Real-World Outcomes

Dr. Juan Manuel Pérez - 3 June, 2026 0

Oral anticoagulation remains the standard treatment for stroke prevention in patients with atrial fibrillation. However, many patients have a high bleeding risk or contraindications...

Institutional News

Watch Again: Clinical Implications of Structural Heart Interventions — TAVI and MitraClip in Daily Practice

solaci - 4 June, 2026 0

The recording of the webinar “Structural Interventions: TAVI and MitraClip in Daily Practice” is now available on the SOLACI YouTube channel. The activity was...

06/03 | SOLACI Technicians & Nurses Webinar – Clinical Impact of Structural Interventions: TAVI and MitraClip in Current Practice

solaci - 2 June, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI), through its Technicians and Nurses Department, invites you to participate in a new scientific webinar entitled...

Open Session | Current Endovascular Treatment of Tricuspid Regurgitation

solaci - 1 June, 2026 0

SOLACI and the Argentine College of Interventional Cardioangiologists (CACI) invite you to participate in a new Open Session of the Advanced Postgraduate Course in...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy

SOLACI-CACI 2021 | SAC-FAC Session

Can Ticagrelor Prevent Strokes in High-Risk Patients?

ESC 2021 | ENVISAGE-TAVI AF: Surprise with Endoxaban in TAVR and Atrial Fibrillation

HOST-EXAM: The Study that Challenges Aspirin as Long-Term Antiplatelet Therapy

ESC 2021 | STEP: Blood Pressure Values in the Elderly, A Never-Ending Debate

ESC 2021 | GREENNESS: Surprising New Protective Factor against Cardiovascular Disease

ESC 2021 | Empagliflozin in Heart Failure with Reduced and Preserved Ejection Fraction

ESC 2021 | ISAR-REACT 5: Prasugrel Superior to Ticagrelor in ACS across Kidney Function Spectrum